Literature DB >> 20452185

Bisphosphonate coating might improve fixation of dental implants in the maxilla: a pilot study.

J Abtahi1, P Tengvall, P Aspenberg.   

Abstract

This pilot study evaluates the clinical stability of bisphosphonate-coated dental implants placed using a two-stage surgical procedure in five patients. Each patient received seven regular Brånemark implants, one of which was coated with bisphosphonate in a fibrinogen matrix. The coated implant was inserted where the bone was expected to have the least favourable quality. The level of the marginal bone around each implant was measured by intraoral periapical radiographs and implant stability was recorded using resonance frequency measurements. Frequency values (ISQ) were obtained peroperatively before flap closure and after 6 months at abutment connection. At abutment connection the bisphosphonate-coated implants were removed en bloc in two patients for histological examination. An animal experiment had previously confirmed that gamma-sterilization did not reduce bioactivity of the bisphosphonate coating. In each patient, the bisphosphonate-coated implant showed the largest improvement in ISQ level of all implants. Their values at the start tended to be lower, and the absolute value at 6 months did not differ. No complications occurred with the coated implants. Histology showed no abnormalities. Improvement in ISQ values was an expected effect of the bisphosphonate coating, but could be due to the choice of insertion site. This finding warrants a randomized, blinded study. Copyright 2010 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20452185     DOI: 10.1016/j.ijom.2010.04.002

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  8 in total

1.  Osteopathology induced by bisphosphonates and dental implants: clinical observations.

Authors:  Christine Jacobsen; Philipp Metzler; Matthias Rössle; Joachim Obwegeser; Wolfgang Zemann; Klaus-Wilhelm Grätz
Journal:  Clin Oral Investig       Date:  2012-03-15       Impact factor: 3.573

Review 2.  Mimicking growth factors: role of small molecule scaffold additives in promoting tissue regeneration and repair.

Authors:  Nowsheen Goonoo; Archana Bhaw-Luximon
Journal:  RSC Adv       Date:  2019-06-10       Impact factor: 4.036

3.  The influence of local delivery of bisphosphonate on osseointegration of dental implants.

Authors:  Aya K Khamis; Sherif Elsharkawy
Journal:  Evid Based Dent       Date:  2018-10

4.  Peri-implant and systemic effects of high-/low-affinity bisphosphonate-hydroxyapatite composite coatings in a rabbit model with peri-implant high bone turnover.

Authors:  Shun Niu; Xiaorui Cao; Yan Zhang; Qingsheng Zhu; Jinyu Zhu; Ping Zhen
Journal:  BMC Musculoskelet Disord       Date:  2012-06-11       Impact factor: 2.362

5.  Biofunctionalization of titanium surfaces with alendronate and albumin modulates osteoblast performance.

Authors:  Carolina Simão Albano; Anderson Moreira Gomes; Geórgia da Silva Feltran; Célio Junior da Costa Fernandes; Luciana Daniele Trino; Willian Fernando Zambuzzi; Paulo Noronha Lisboa-Filho
Journal:  Heliyon       Date:  2020-07-21

Review 6.  Bisphosphonate releasing dental implant surface coatings and osseointegration: A systematic review.

Authors:  Shariq Najeeb; Muhammad S Zafar; Zohaib Khurshid; Sana Zohaib; Syed M Hasan; Rabia S Khan
Journal:  J Taibah Univ Med Sci       Date:  2017-06-17

7.  Early tissue responses to zoledronate, locally delivered by bone screw, into a compromised cancellous bone site: a pilot study.

Authors:  Joerg Arnoldi; Antoine Alves; Philip Procter
Journal:  BMC Musculoskelet Disord       Date:  2014-03-23       Impact factor: 2.362

8.  Guided bone regeneration with local zoledronic acid and titanium barrier: An experimental study.

Authors:  Serkan Dundar; Cem Ozgur; Ferhan Yaman; Omer Cakmak; Arif Saybak; Ibrahim Hanifi Ozercan; Hilal Alan; Gokhan Artas; Onur Nacakgedigi
Journal:  Exp Ther Med       Date:  2016-08-12       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.